Siegfried Priglinger
Novartis (Switzerland)(CH)Martin University(US)LMU Klinikum(DE)Augenklinik Heidelberg(DE)Rotterdam Eye Hospital(NL)München Klinik(DE)Ludwig-Maximilians-Universität München(DE)University of Sheffield(GB)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Glaucoma and retinal disorders, Retinal and Macular Surgery, Corneal surgery and disorders, Intraocular Surgery and Lenses
Most-Cited Works
- → INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA(2006)453 cited
- → Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial(2023)278 cited
- → The Protective Effect of Quercetin against Oxidative Stress in the Human RPE In Vitro(2008)157 cited
- → COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE(2017)152 cited
- → An in vivo evaluation of Brilliant Blue G in animals and humans(2008)148 cited
- Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin.(2002)
- →